The 20 Best Undifferentiated Pleomorphic Sarcoma Doctors near Basking Ridge, NJ

James Wittig is an Orthopedics provider in Morristown, New Jersey. Dr. Wittig is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Hip Replacement, and Knee Replacement.

Lawrence Harrison, MD, is chief of Atlantic Surgical Oncology, which provides expert care across a broad spectrum of cancers, focusing on hepatobiliary, pancreatic, colorectal, gastroesophageal, skin and soft tissue cancers. As fellowship-trained surgical oncologists, Dr. Harrison and his partners provide patients with the latest in surgical innovations and clinical research options. Atlantic Surgical Oncology works closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and at Overlook Medical Center in Summit. Dr. Harrison has been a surgical innovator since finishing fellowship training at Memorial Sloan Kettering Cancer Center in New York City. He has extensive training in novel surgical techniques, including in hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery. Prior to joining Atlantic Surgical Oncology, Dr. Harrison served as director of surgical oncology at Valley Hospital in Ridgewood where he developed expertise in robotic surgery, performing more than 200 complex robotic surgical procedures. He also was director of the Advanced Gastrointestinal Surgical Fellowship. Previously, Dr. Harrison was associate professor of surgery and chief of the Division of Surgical Oncology at University Hospital in Newark for 12 years. In addition to his clinical practice, he was involved in research and taught medical residents and students. He is a fellow of the American College of Surgeons. Dr. Harrison sees patients at Morristown and Overlook medicals centers, and provides consultative services to Newton, Chilton and Hackettstown medical centers. Dr. Harrison is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Dr. Kai Bickenbach provides cancer patients with exceptional surgical care at Atlantic Surgical Oncology. His areas of specialty include melanoma, sarcoma, pancreatic cancer, liver and biliary cancer, esophageal and gastric cancer and colorectal cancer. He is trained in the use of many novel therapies, including the NanoKnife® to treat un-resectable pancreatic and liver tumors, as well as hepatic arterial infusion pumps. Dr. Bickenbach and his partners are fellowship trained surgical oncologists providing patients the latest in surgical innovation and clinical research options. Atlantic Surgical Oncology Associates work closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and Overlook Medical Center in Summit. Dr. Bickenbach is a member of a variety of medical organizations including the American College of Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the Americas Hepato-Pancreatico-Biliary Association, and is a councilman for the New Jersey Chapter of the American College of Surgeons. He is widely published and has presented at national meetings on cancer related topics.After graduating from Wayne State University School of Medicine in 2002, Dr. Bickenbach completed his surgical residency at the University of Chicago Medical Center in 2009, where he was elected administrative chief resident. During that time, Dr. Bickenbach completed a two-year research fellowship, focusing on the use of oncolytic viruses in the treatment of cancer. Following residency, Dr. Bickenbach completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He sees patients at Morristown, Overlook, Newton, Chilton and Hackettstown medical centers. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Bickenbach is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Ciara Kelly is an Oncologist in Basking Ridge, New Jersey. Dr. Kelly is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Merkel Cell Carcinoma, and Liposarcoma. Dr. Kelly is currently accepting new patients.

Jeffrey Girshman is a Radiologist in Basking Ridge, New Jersey. Dr. Girshman is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Gastric Lymphoma, WT1-Related Wilms Tumor Syndromes, Lymphoid Hyperplasia, and Renal Cell Carcinoma (RCC).

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

David Gallinson is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gallinson is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is currently accepting new patients.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Neil Shah is a Radiologist in Morristown, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Pleurisy, Pleural Effusion, Nasal Flaring, and Colonic Malakoplakia. Dr. Shah is currently accepting new patients.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Yvette Ho, MD, is a fellowship-trained orthopedic surgeon specializing in orthopedic oncology with Atlantic Medical Group (AMG). Board-certified in orthopedic surgery by the American Board of Orthopaedic Surgery, she has clinical expertise in evaluating and treating pediatric and adult patients with bone and soft tissue sarcomas, metastatic disease and benign and malignant bone and soft tissue tumors of the extremities, pelvis and shoulder girdle. She is also certified in the use of the Mako robot for total/partial knee and total hip replacement. A compassionate caregiver, Dr. Ho uses minimally invasive surgical techniques whenever possible for easier recovery and fewer complications.After earning her medical degree at Georgetown University School of Medicine in Washington, DC, Dr. Ho performed an orthopedic surgery residency and concurrent research residency at Maimonides Medical Center in Brooklyn, NY. She then received additional specialized fellowship training in orthopedic oncology at MD Anderson Cancer Center in Houston, TX. Prior to joining AMG, she held positions as an orthopedic oncology surgeon in the Washington, DC metro area and Houston, TX.The author of several publications in peer-reviewed medical journals, Dr. Ho has also presented multiple times at national and international medical conferences. She served as a co-investigator in research projects covering anti-cancer therapies in patients with solid tumors and creating 3-D cell cultures of sarcoma specimens. Dr. Ho also is very interested in educating the next generation of orthopedic surgeons, lecturing residents on various topics in orthopedic oncology.Dr. Ho is a fellow of the American Academy of Orthopaedic Surgeons and a member of the American Medical Association, Musculoskeletal Tumor Society, Texas Medical Association, Harris County Medical Society, and the Maryland State Medical Society. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Desmoid Tumor, Infantile Myofibromatosis, Congenital Generalized Fibromatosis, Bone Tumor, and Hip Replacement.

Marc Simmons is a Radiologist in Basking Ridge, New Jersey. Dr. Simmons is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Lymphoid Hyperplasia, ALK-Positive Non-Small Cell Lung Cancer, and Varicocele.

Jean Torrisi is a Radiologist in Basking Ridge, New Jersey. Dr. Torrisi is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Synovial Sarcoma, Rhabdoid Tumor Predisposition Syndrome, Rhabdoid Tumor, and Ascites.

Stefanie Jacobs is a Radiologist in Basking Ridge, New Jersey. Dr. Jacobs is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Pleuropulmonary Blastoma, Breast Lump, ALK-Positive Non-Small Cell Lung Cancer, and EGFR Positive Lung Cancer.

Linda Aboody is a Radiologist in Basking Ridge, New Jersey. Dr. Aboody is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Breast Lump, Gastric Lymphoma, Lymphoid Hyperplasia, and Galactocoele.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Lawrence Swayne is a Radiologist in Morristown, New Jersey. Dr. Swayne is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Pleural Effusion, Pleurisy, Melorheostosis, and Osteopenia.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.